INNITIUS

CE-certified

CerviSense provides actionable assessment across the entire pregnancy journey

It enables healthcare professionals to make faster, more accurate decisions in critical obstetric scenarios.

CerviSense medical device for objective cervical consistency measurement.
Electrical safety
IEC60601-1 Compliant
Biocompatibility
ISO 10993 Compliant
Patient experience
Validated comfort and usability
Reproducibility
91 % achieved across users

One probe, three clinical applications

A single probe, powered by condition-specific AI models, analyzes cervical consistency to support obstetric assessments.

Spontaneous preterm labor

Early risk detection
Week 20

Threatened preterm labor

Accurate triage
Week 24-37

Induction of labor

Early risk detection
Week 37+

Obstetricians have always felt cervical consistency with their fingers

For the first time, it can be measured, compared, and tracked objectively across patients and visits.

Hardware precision

Torsional waves capture the cervix’s biomechanical signature using a proprietary torsional wave transducer.

Standardized acquisition

The same technique delivers the same output regardless of the operator, with automatic and consistent data transfer.

Quantified consistency

Objective data replaces the variability of vaginal examination, supported by a touchscreen that guides the clinician step by step.

Clinical studies

StudyCountry / RegionPatientsStatus
FB-CT2 Pivotal Study
(Threatened Preterm Labor)
Spain & Germany457Ongoing
QEPS (Spontaneous
Preterm Labor)
United Kingdom1,000Ongoing
MATERN-AID
(Induction of Labor)
Sweden500Preparation phase
Project HOPESenegal, Cameroon,
Nigeria, Congo DR
Not
specified
Preparation phase
  • CerviSense science